Inactive Instrument

Canadian Cannabis Corp. Stock Other OTC

Equities

CCAN

US1354421018

Advertising & Marketing

Dynamic Chart
Canadian Cannabis Corp. cancelled the acquisition of Tree of Knowledge, Inc. CI
Canadian Cannabis Corp. signed a letter of intent to acquire Tree of Knowledge, Inc. CI
Canadian Cannabis Corp. cancelled the acquisition of 60% stake in Hemisphere Pharmaceutical Inc. CI
Canadian Cannabis Corp. cancelled the acquisition of The Hydropothecary Corporation. CI
Canadian Cannabis Corp. agreed to acquire The Hydropothecary Corporation for $21.3 million. CI
Canadian Cannabis Corp. Auditor Raises 'Going Concern' Doubt CI
Canadian Cannabis Corp. Announces Resignation of John Esteireiro as Director and Chief Operating Officer CI
Canadian Cannabis Corp. cancelled the acquisition of 61% stake in Novo Healthnet Limited. CI
Canadian Cannabis Corp. signed a letter of intent to acquire 60% stake in Hemisphere Pharmaceutical Inc. for $6.2 million. CI
Canadian Cannabis Corp. Appoints Richard Wachsberg as Independent Director CI
Canadian Cannabis Corp. entered into a binding letter of intent to acquire 61% stake in Novo Healthnet Limited for $9.6 million. CI
Canadian Cannabis Corp. Announces Resignation of Silvio Serrano as Director and Vice President CI
Gold Party Payday Inc. will Change its Ticker to GPAYE from GPAY CI
Gold Party Payday Inc. Announces Management Changes CI
Gold Party Payday, Inc. Amends Certificate of Incorporation and Bylaws; Changes Fiscal Year End from September 30 to December 31 of Each Year CI
More news
Canadian Cannabis Corp., formerly Gold Party Payday, Inc., is an early stage company. The Company, through its subsidiary Canada Cannabis Corp., is engaged in cultivating, marketing and manufacturing medical marijuana products for sale in Canada. The Company focuses to offer approximately 15 different strains of dried marijuana, as well as the constituents necessary to produce edible and elixir products for medicinal use. The Company is also focused to produce chemical variants of products tailored to treatment protocols.
More about the company